Drug recall D-0616-2021
Product
NovoLog (Insulin aspart) Injection, 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark NDC 0169-7501-90
Reason for recall
Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Lots and codes
JZFC826 exp 06/30/2021; KZFM305 exp 08/31/2022
Recall details
- Recalling firm
- Novo Nordisk Inc, Plainsboro, NJ
- Quantity
- N/A
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 22, 2021
- Terminated
- December 9, 2022
Related products
- Insulin Diluting Medium for NovoLog – drug information
- NDC 0169-2100 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-2101 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-7501 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-2001 Insulin Diluting Medium for NovoLog · Water 1 mL/mL · Novo Nordisk
- NDC 0169-6338 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-6339 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk
- NDC 0169-3303 Novolog · Insulin Aspart 100 [iU]/mL · Novo Nordisk